Colgate-Palmolive Company

(New York Stock Exchange)
Back to all articles
Somewhat Bearish -35

Colgate-Palmolive (CL) Stock Forecast & Price Target (2026)

AI-generated analysis

📉 CL trades at $87.47, aligning with CleaRank's fair value but remaining below the Wall Street consensus target of $100.50.

📊 Technical indicators show a bearish short-term outlook as the stock sits below its 50-day and 200-day moving averages with negative MACD momentum.

💰 Insiders have sold over $57.3 million in CL stock with no reported purchases, signaling potential management lack of confidence.

📈 Recent quarters saw CL beat EPS estimates, yet the stock price declined, suggesting earnings are not currently driving valuation.

🎯 The RSI is at 29.13, indicating oversold conditions that could trigger a short-term technical bounce or reversal.

🔮 Monte Carlo simulations project a base case price of $104 for CL by 2030, assuming no dividend reinvestment.

Bullish Signals
  • Colgate-Palmolive has beaten EPS estimates in recent quarters, demonstrating operational profitability despite stock price weakness.
  • The Relative Strength Index (RSI) is at 29.13, indicating oversold conditions that historically could precede a short-term technical bounce or reversal.
Risk Factors
  • Insiders have sold over $57.3 million worth of CL stock with no reported purchases, indicating a significant lack of confidence from management.
  • The stock is trading below its 50-day average of $90.86 and 200-day moving average of $88.08, suggesting continued potential for price declines.
  • Negative MACD momentum indicates a bearish short-term technical outlook for the company.
Full Analysis
As of September 19, 2026, Colgate-Palmolive (CL) is trading at $87.47, which aligns with CleaRank Financial AI's fair value but falls below the Wall Street consensus target of $100.50 set by 21 analysts. Technical indicators suggest a bearish short-term outlook, with the stock trading below its 50-day average of $90.86 and 200-day moving average of $88.08, accompanied by negative MACD momentum. Despite recent quarters where Colgate-Palmolive beat EPS estimates, the stock price has continued to decline, indicating that current earnings performance is not acting as a catalyst for upward price movement. Technical analysis highlights an RSI of 29.13, placing the stock in oversold territory which could precede a short-term technical bounce or reversal. Insider trading data reveals a significant lack of confidence from management, with insiders having sold over $57.3 million worth of CL stock and no reported purchases. Long-term simulations project a base case price near $104 by 2030, representing a 1.2x increase from current levels, while downside scenarios could see the price drop to approximately $62.12.